Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro

Journal of Molecular Neuroscience

Volumn 38, Issue 1, 2009, Pages 2-11

  Franco Pons, Neus ^a,b   Tomàs, Jordi ^a,b   Roig, Bárbara ^a,b   Auladell, Carme ^c   Martorell, Lourdes ^a,b   Vilella, Elisabet ^a,b  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^b IISPV   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

CNPase; Cuprizone; DDR1; HOG16 cells; Myelin; OLIG2; Schizophrenia

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; APC PROTEIN; CARNOSINE; CD11B ANTIGEN; CUPRIZONE; DISCOIDIN DOMAIN RECEPTOR 1; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; MYELIN PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; DISCOIDIN RECEPTOR; LECTIN RECEPTOR; MONOAMINE OXIDASE INHIBITOR; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FORNIX; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REMYELINIZATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; MYELIN SHEATH; PHYSIOLOGY; SCHIZOPHRENIA;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CORPUS CALLOSUM; CUPRIZONE; HUMANS; MALE; MICE; MODELS, ANIMAL; MONOAMINE OXIDASE INHIBITORS; MYELIN PROTEINS; MYELIN SHEATH; OLIGODENDROGLIA; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, MITOGEN; RNA, MESSENGER; SCHIZOPHRENIA; UP-REGULATION;

EID: 68949204211     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9151-x     Document Type: Article

References (38)

1. Abdulhussein, R., McFadden, C., Fuentes-Prior, P., & Vogel, W. F. (2004). Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor. The Journal of Biological Chemistry, 279, 31462-31470. doi:10.1074/jbc.M400651200. (Pubitemid 39037814)
2. Agarwal, G., Mihai, C., & Iscru, D. F. (2007). Interaction of discoidin domain receptor 1 with collagen type 1. Journal of Molecular Biology, 367, 443-455. doi:10.1016/j.jmb.2006.12.073. (Pubitemid 46295432)
3. Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P. (2001). TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neuroscience, 4, 1116-1122. doi:10.1038/nn738. (Pubitemid 34116557)
4. Arnett, H. A., Wang, Y., Matsushima, G. K., Suzuki, K., & Ting, J. P. (2003). Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. The Journal of Neuroscience, 23, 9824-9832.
5. Baumann, N., & Pham-Dinh, D. (2001). Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiological Reviews, 81, 871-927.
6. Bhatt, R. S., Tomoda, T., Fang, Y., & Hatten, M. E. (2000). Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. Genes & Development, 14, 2216-2228. doi:10.1101/gad.821600. (Pubitemid 30677961)
7. Buntinx, M., Vanderlocht, J., Hellings, N., et al. (2003). Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocytespecific gene expression. Journal of Neurocytology, 32, 25-38. doi:10.1023/A:1027324230923. (Pubitemid 37518586)
8. Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002). Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. The New England Journal of Medicine, 346, 165-173. doi:10.1056/NEJMoa010994. (Pubitemid 34438882)
9. Davis, K. L., Stewart, D. G., Friedman, J. I., et al. (2003). White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry, 60, 443-456. doi:10.1001/archpsyc.60.5.443. (Pubitemid 36539053)
10. Franco-Pons, N., Torrente, M., Colomina, M. T., & Vilella, E. (2007). Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. Toxicology Letters, 169, 205-213. doi:10.1016/j.toxlet.2007.01.010. (Pubitemid 46436370)
11. Franco-Pons, N., Virgos, C., Vogel, W. F., et al. (2006). Expression of discoidin domain receptor 1 during mouse brain development follows the progress of myelination. Neuroscience, 140, 463-475. doi:10.1016/j.neuroscience.2006.02. 033. (Pubitemid 44255523)
12. Franklin, R. J., & Hinks, G. L. (1999). Understaning CNS remyelination: clues from developmental and regeneration biology. Journal of Neuroscience Research, 58, 207-213. doi:10.1002/(SICI)1097-4547(19991015)58: 2<207::AIDJNR1>3.0.CO;2-1.
13. Hiremath, M. M., Saito, Y., Knapp, G. W., Ting, J. P., Suzuki, K., & Matsushima, G. K. (1998). Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. Journal of Neuroimmunology, 92, 38-49. doi:10.1016/S01655728(98)00168-4.
14. Hou, G., Vogel, W. F., & Bendeck, M. P. (2002). Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression. Circulation Research, 90, 1147-1149. doi:10.1161/01.RES. 0000022166.74073.F8.
15. Jonsson, M., & Andersson, T. (2001). Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. Journal of Cell Science, 114, 2043-2053.
16. Kamohara, H., Yamashiro, S., Galligan, C., & Yoshimura, T. (2001). Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes migration of leukocytes in three-dimensional collagen lattices. The FASEB Journal, 15, 2724-2726.
17. Liebetanz, D., & Merkler, D. (2006). Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Experimental Neurology, 202, 217-224. doi:10.1016/j.expneurol.2006. 05.032. (Pubitemid 44344263)
18. Ligon, K. L., Fancy, S. P. J., Franklin, R. J. M., & Rowitch, D. H. (2006). Olig gene function in CNS development and disease. Glia, 54, 1-10. doi:10.1002/glia.20273. (Pubitemid 43980029)
19. Mason, J. L., Jones, J. J., Taniike, M., Morell, P., Suzuki, K., & Matsushima, G. K. (2000). Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. Journal of Neuroscience Research, 61, 251-262. doi:10.1002/ 1097-4547(20000801)61 3<251::AID-JNR3>3.0.CO;2-W
20. Mason, J. L., Langaman, C., Morell, P., Suzuki, K., & Matsushima, G. K. (2001). Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathology and Applied Neurobiology, 27, 50-58. doi:10.1046/j.0305-1846.2001.00301.x. (Pubitemid 32293591)
21. Mason, J. L., Toews, A., Hostettler, J. D., et al. (2004). Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. American Journal of Pathology, 164, 1673-1682.
22. Matsushima, G. K., & Morell, P. (2001). The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathology (Zurich, Switzerland), 11, 107-116.
23. Matsuyama, W., Faure, M., & Yoshimura, T. (2003). Activation of discoidin domain receptor 1 facilitates the maturation of human monocyte-derived dendritic cells through the TNF receptor associated factor 6/TGF-beta-activated protein kinase 1 binding protein 1 beta/p38 alpha mitogen-activated protein kinase signaling cascade. Journal of Immunology 171, 3520-3532, Baltimore MD. 1950.
24. McInnes, L. A., & Lauriat, T. L. (2006). RNA metabolism and dysmyelination in schizophrenia. Neuroscience and Biobehavioral Reviews, 30, 551-561. doi:10.1016/j.neubiorev.2005.10.003.
25. Morell, P., Barrett, C. V., Mason, J. L., et al. (1998). Gene expression in brain during cuprizone-induced demyelination and remyelination. Molecular and Cellular Neurosciences, 12, 220-227. doi:10.1006/mcne.1998.0715. (Pubitemid 28536075)
26. Nait-Oumesmar, B., Decker, L., Lachapelle, F., Avellana-Adalid, V., Bachelin, C., & Van Evercooren, A. B. (1999). Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. The European Journal of Neuroscience, 11, 4357-4366. doi:10.1046/ j.1460-9568.1999.00873.x.
27. Paxinos, G., & Franklin, K. B. J. (2001). The mouse brain in stereotaxic coordinates. San Diego: Academic.
28. Roig, B., Virgos, C., Franco, N., et al. (2007). The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia. Molecular Psychiatry, 12, 833-841. doi:10.1038/sj.mp.4001995. (Pubitemid 47347792)
29. Sanchez, M. P., Tapley, P., Saini, S. S., He, B., Pulido, D., & Barbacid, M. (1994). Multiple tyrosine protein kinases in rat hippocampal neurons: isolation of Ptk-3, a receptor expressed in proliferative zones of the developing brain. Proceedings of the National Academy of Sciences of the United States of America, 91, 1819-1823. doi:10.1073/pnas.91.5.1819.
30. Stidworthy, M. F., Genoud, S., Suter, U., Mantei, N., & Franklin, R. J. (2003). Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathology (Zurich, Switzerland), 13, 329-339.
31. Vogel, W., Gish, G. D., Alves, F., & Pawson, T. (1997). The discoidin domain receptor tyrosine kinases are activated by collagen. Molecular Cell, 1, 13-23. doi:10.1016/S1097-2765 (00)80003-80009
32. Vogel, W. F., Aszodi, A., Alves, F., & Pawson, T. (2001). Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Molecular and Cellular Biology, 21, 2906-2917. doi:10.1128/MCB.21. 8.2906-2917. 2001.
33. Walterfang, M., Wood, S. J., Velakoulis, D., & Pantelis, C. (2006). Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. Neuroscience and Biobehavioral Reviews, 30, 918-948. doi:10.1016/j.neubiorev. 2006.02.001.
34. Wang, C. Z., Hsu, Y. M., & Tang, M. J. (2005). Function of discoidin domain receptor I in HGF-induced branching tubulogenesis of MDCK cells in collagen gel. Journal of Cellular Physiology, 203, 295-304. doi:10.1002/jcp. 20227. (Pubitemid 40328196)
35. Walterfang, M., Wood, S. J., Velakoulis, D., & Pantelis, C. (2006). Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. Neuroscience and Biobehavioral Reviews, 30, 918-948. doi:10.1016/j.neubiorev. 2006.02.001.
36. Xiao, L., Xu, H., Zhang, Y., et al. (2008). Quetiapine facilitates oligodendrocyte development and prevents mice for myelin breakdown and behavioral changes. Molecular Psychiatry, 13 (7), 897-708. doi:10.1038/sj.mp. 4002064. (Pubitemid 351861531)
37. Zawadzka, M., & Franklin, R. J. (2007). Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology. Current Opinion in Neurology, 20, 294-298. doi:10.1097/WCO.0b013e32813aee7f. (Pubitemid 46743111)
38. Zerlin, M., Julius, M. A., & Goldfarb, M. (1993). NEP: a novel receptor-like tyrosine kinase expressed in proliferating neuroepithelia. Oncogene, 8, 2731-2739.